T5373 |
Acrizanib
|
1229453-99-9
|
98.72%
|
|
Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2.
|
T22737 |
DMH4
|
515880-75-8
|
98.68%
|
|
DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 µM.
|
T8496 |
MAZ51
|
163655-37-6
|
98.53%
|
|
MAZ51 is a VEGFR-3 (Flt-4) tyrosine kinase inhibitor.
|
T10870L |
CP-547632
|
252003-65-9
|
98.51%
|
|
CP-547632 is an orally available and potent, ATP-competitive dual inhibitor of VEGFR-2 and FGF kinase F with IC50s of 11 nM and 9 nM, respectively. CP-547632 is ...
|
T22436 |
Takeda-6d
|
1125632-93-0
|
98.41%
|
|
Takeda-6d, a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits B-RAF and VEGFR2 with IC50 of 7.0nM and 2.2nM.
|
T0374L |
Sunitinib
|
557795-19-4
|
98.38%
|
|
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and PDGFRβ (IC50=80/2 nM). Sunitinib has antitumor activit...
|
T6028 |
PF 477736
|
952021-60-2
|
98.34%
|
|
PF 477736 (PF-736,PF-00477736) is a specifc, effective and ATP-competitive Chk1 inhibitor (Ki: 0.49 nM ) and also inhibits FGFR3, Aurora-A, VEGFR2, Flt3, Fms (CS...
|
T3691 |
(Rac)-SAR131675
|
1092539-44-0
|
98.34%
|
|
(Rac)-SAR131675 is an effective and specific VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity (IC50: 20 nmol/L) and VEGFR-3 autophosphorylation (...
|
T6199 |
Ribociclib
|
1211441-98-3
|
98.27%
|
|
Ribociclib (LEE011) is an orally available, and highly specific CDK4/6 inhibitor (IC50:10/39 nM).
|
T3560 |
Desmethylanethol trithione
|
18274-81-2
|
98.23%
|
|
Desmethylanethol trithione (ADT-OH) is a derivative of anethole dithiolethione (ADT) and synthetic hydrogen sulfide (H2S) donor. In the in vitro glucose-oxygen d...
|
T0374 |
Sunitinib Malate
|
341031-54-7
|
98.23%
|
|
Sunitinib Malate (Sunitinib) is an indolinone-based tyrosine kinase inhibitor. It blocks the tyrosine kinase activities of VEGFR2, PDGFRβ (IC50: 80/2 nM), and c-...
|
T2456 |
Tivozanib
|
475108-18-0
|
98.23%
|
|
Tivozanib (KRN951) is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and anti...
|
T30855 |
CGP77675
|
234772-64-6
|
98.23%
|
|
CGP77675 (ZINC1488120) is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates and au...
|
T4053 |
AST 487
|
630124-46-8
|
98.17%
|
|
AST 487 (NVP-AST 487) is a RET kinase inhibitor, inhibiting RET autophosphorylation and activation of downstream effectors. It also can inhibit Flt-3.
|
T2642 |
PD173074
|
219580-11-7
|
98.15%
|
|
PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50: 100-200 nM) in cell-free assays. The selectivity is higher ~1000-fold for ...
|
T26852 |
BMS-605541
|
639858-32-5
|
98.07%
|
|
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM).
|
T3641 |
NVP-BAW2881
|
861875-60-7
|
98.07%
|
|
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit ...
|
T61899 |
VEGFR2-IN-1
|
2765224-55-1
|
98.06%
|
|
VEGFR2-IN-1 is a selective and potent VEGFR2 inhibitor with antitumor activity that inhibits cell proliferation and migration and can be used in the study of bre...
|
T22349 |
JNJ-38158471
|
951151-97-6
|
98.04%
|
|
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such ...
|
TQ0321 |
BIBF 1202
|
894783-71-2
|
98.04%
|
|
BIBF 1202 is a VEGFR2 kinase inhibitor (IC50: 62 nM).
|